Precision radiation zaps returned prostate cancer, sparing healthy tissue
NCT ID NCT03312972
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 22 times
Summary
This study tests a focused radiation treatment called HDR brachytherapy for men whose prostate cancer has returned after earlier radiation. The treatment places a temporary radioactive source directly into the tumor area, aiming to destroy cancer while protecting normal prostate tissue. The study includes 50 participants and will track safety and side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY RECURRENT PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Loyola University Medical Center
Maywood, Illinois, 60153, United States
-
University of Virginia School of Medicine
Charlottesville, Virginia, 22908, United States
Conditions
Explore the condition pages connected to this study.